Peptide Cancer Vaccine Market Size And Share

  • Report Code : TIPRE00027673
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

2025-2031年肽类癌症疫苗市场规模、份额及预测

Buy Now

Peptide Cancer Vaccine Market Report Analysis

Peptide Cancer Vaccine Market

  • CAGR (2025 - 2031)
    20.2%
  • Market Size 2024
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • Enzo Life Science
  • Immatics Biotechnologies
  • TapImmune
  • Merck
  • BrightPath Biotherapeutics
  • Sellas
  • BioLife Science
  • Boston Biomedical
  • VAXON Biotech

Regional Overview

  • 北美
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲

Market Segmentation

By 癌症类型
  • 乳腺癌
  • 肺癌
  • 黑色素瘤
  • 前列腺癌
  • 其他
By 疫苗类型
  • 个体化肽疫苗
  • 肽脉冲树突状癌症疫苗
  • 肽鸡尾酒型
  • 多价肽疫苗
  • 其他
By 地理
  • 北美洲
  • 欧洲
  • 亚太地区
  • 南美洲和中美洲
  • 中东和非洲